Substance P-Mediated Cardiovascular Inflammation
Substance P-Mediated Cardiovascular Inflammation
批准号:
7174228
负责人:
William Bernard Weglicki
金额:
$28.82万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-02-01 至 2009-01-31
关键词:
AcuteAddressAlcoholismAntibioticsAntioxidantsAttenuatedBacterial InfectionsBiochemicalBiologyBlood CirculationC FiberCD14 AntigenCapsaicinCardiacCardiomyopathiesCardiovascular systemCellsChronicCollaborationsComplexDataDefectDetectionDevelopmentDiabetes MellitusDietDietary intakeDinoprostoneDiseaseDiureticsDue ProcessElevationEndotoxemiaEndotoxinsEpithelial CellsEventExhibitsFree RadicalsFunctional disorderGene ChipsGenerationsGeneticGlutathioneHIV InfectionsHeadHeartHeart failureHematopoieticHistamineInfiltrationInflammationInflammatoryInflammatory disease of the intestineInjuryInterleukin-1Interleukin-6InterventionIntestinesIschemiaIsoprostanesLeadLipid PeroxidationLocalizedMediatingMesenteryMethodsModelingMolecularMucous MembraneMusMuscle functionMyocardialMyocardial IschemiaN-Methyl-D-Aspartate ReceptorsN-MethylaspartateNeprilysinNeurogenic InflammationNeurogliaNeuronsNeuropeptidesNeutrophil InfiltrationNitric OxideOrganOxidative StressPathogenesisPatternPeptidesPermeabilityPharmacotherapyPhasePhysiological reperfusionPlasmaPortal vein structurePredispositionPrincipal InvestigatorProcessProductionProtease InhibitorProteinsRattusReactive Oxygen SpeciesReceptor ActivationRecovery of FunctionReperfusion TherapyResearchResiniferatoxinResistanceReverse Transcriptase Polymerase Chain ReactionRisk FactorsRodentRodent ModelRoleScreening procedureSepsis SyndromeSignal TransductionSpin TrappingSpinal CordSpinal GangliaStagingSterilization for infection controlStressSubstance PSubstance P ReceptorT-LymphocyteTechniquesTechnologyTextTissue-Specific Gene ExpressionTissuesVascular Endothelial Growth FactorsWeekWestern Blottinganalogbaseclinically relevantcytokinedaydienedietary restrictionfunctional disabilitygastrointestinal systemimprovedin vivointercellular cell adhesion moleculemacrophageneutrophiloxidationphosphoramidonprogramsreceptor expressionrelating to nervous systemresponsesynergismwasting
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal addresses the pathobiology of inflammation of the heart due to neurogenic peptides, particularly substance P (SP). Recent data have provided support for the neuronal NMDA receptor contribution to the cardiovascular inflammatory process due to Mg-deficiency (MgD). In addition concurrent intestinal inflammation may enhance the later phase of the cardiomyopathy via activation of PMNs and endotoxin signaling. These recent findings provide the basis for the following Aims and collaborations: Aim 1. Assess the contribution of NMDA-receptor activation to the early SP elevation and how SP can be modulated during the acute "trigger phase" of dietary MgD. Aim 2. Determine the extent of NK-1 receptor expression and proinflammatory/oxidative response in the circulation and cardiac tissues during MgD. Aim 3. (with Dr. Shea-Donohue) Assess if MgD induces a neurogenic inflammation in the gut that is associated with altered intestinal function, enhanced mucosa barrier permeability, and increased sensitivity to oxidative stress; assess if systemic inflammatory response syndrome (SIRS) or endotoxemia contribute significantly to "cardiac inflammation/cardiomyopathy at a distance." Aim 4. Assess whether defects in baseline contractility of perfused rat heads develops during the late response phase of MgD and if in vivo interventions (MK-801, NK-1 receptor blocker, RTX, phosphoramidon, antibiotics) have a significant impact on cardiac baseline contractility dysfunction and tolerance to ltR stress. Aim 5. Assess if proinflammatory effects of MgD are altered in LPS-resistant vs. sensitive mice. We will employ a combination of immunohistochemical and molecular/protein biology (RT-PCR, Western-blotting) techniques, and gene chip technology to assess relevant genetic expression; more traditional biochemical (tissue glutathione and antioxidant status, plasma isoprotane level) and biophysical (ESR-spin trapping of free radicals and NO in isolated perfused heads) approaches will also be used.The hypotheses to be pursued in the Research Plan are outlined in Illustration 1. The potential relevance of clinical MgD to proinflammatory events in heart failure and other disease processes is addressed in the text.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Chronic dietary Mg2+ deficiency induces cardiac apoptosis in the rat heart.
慢性膳食 Mg2 缺乏会诱导大鼠心脏细胞凋亡。
DOI:
--
发表时间:
2007
期刊:
Magnesium research
影响因子:
3.2
作者:
[Tejero-Taldo,MIsabel, Chmielinska,JoannaJ, Weglicki,WilliamB]
通讯作者:
Weglicki,WilliamB
DOI:
10.1097/maj.0b013e3181aaee4d
发表时间:
2009-07
期刊:
The American journal of the medical sciences
影响因子:
--
作者:
[Kramer JH, Spurney C, Iantorno M, Tziros C, Mak IT, Tejero-Taldo MI, Chmielinska JJ, Komarov AM, Weglicki WB]
通讯作者:
Weglicki WB
Suppression of neutrophil and endothelial activation by substance P receptor blockade in the Mg-deficient rat.
镁缺乏大鼠中 P 物质受体阻断抑制中性粒细胞和内皮细胞活化。
DOI:
--
发表时间:
2003
期刊:
Magnesium research
影响因子:
3.2
作者:
[Mak,ITong, Kramer,JayH, Weglicki,WilliamB]
通讯作者:
Weglicki,WilliamB
DOI:
10.1385/ct:4:2:169
发表时间:
2004-01-01
期刊:
Cardiovascular toxicology
影响因子:
3.2
作者:
[Mak, I Tong, Goldfarb, Maya G, Haudenschild, Christian C]
通讯作者:
Haudenschild, Christian C
Intestinal inflammation caused by magnesium deficiency alters basal and oxidative stress-induced intestinal function.
镁缺乏引起的肠道炎症会改变基础和氧化应激诱导的肠道功能。
DOI:
10.1007/s11010-007-9554-y
发表时间:
2007
期刊:
Molecular and cellular biochemistry
影响因子:
4.3
作者:
[Scanlan,BradfordJ, Tuft,Blaine, Elfrey,JustinE, Smith,Allen, Zhao,Aiping, Morimoto,Motoko, Chmielinska,JoannaJ, Tejero-Taldo,MariaIsabel, Mak,IuTong, Weglicki,WilliamB, Shea-Donohue,Terez]
通讯作者:
Shea-Donohue,Terez
共 11 条
EGFR Tyrosine Kinase Inhibition - Induced Cardiomyopathy
-
批准号:8399041
-
项目类别:
-
资助金额:$15.09万
-
财政年份:2011
-
负责人:William Bernard Weglicki
-
依托单位:
EGFR Tyrosine Kinase Inhibition - Induced Cardiomyopathy
-
批准号:8243940
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2011
-
负责人:William Bernard Weglicki
-
依托单位:
CARDIOMYOPATHY:PRO-OXIDANT ROLE OF AZT & MG-DEFICIENCY
-
批准号:6149273
-
项目类别:
-
资助金额:$34.24万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
OXIDATIVE STRESS AND ANTIOXIDANTS IN IRON OVERLOAD
-
批准号:6090836
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
CARDIOMYOPATHY:PRO-OXIDANT ROLE OF AZT & MG-DEFICIENCY
-
批准号:6537840
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
OXIDATIVE STRESS AND ANTIOXIDANTS IN IRON OVERLOAD
-
批准号:6750773
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Oxidative Stress And Antioxidants in Iron Overload
-
批准号:7421044
-
项目类别:
-
资助金额:$38.58万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Oxidative Stress And Antioxidants in Iron Overload
-
批准号:7825432
-
项目类别:
-
资助金额:$38.58万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Oxidative Stress And Antioxidants in Iron Overload
-
批准号:7259758
-
项目类别:
-
资助金额:$39.9万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
CARDIOMYOPATHY:PRO-OXIDANT ROLE OF AZT & MG-DEFICIENCY
-
批准号:6638667
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
SUBSTANCE P-MEDIATED CARDIOVASCULAR INFLAMMATION
-
批准号:6629015
-
项目类别:
-
资助金额:$31.99万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
OXIDATIVE STRESS AND ANTIOXIDANTS IN IRON OVERLOAD
-
批准号:6390951
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
SUBSTANCE P-MEDIATED CARDIOVASCULAR INFLAMMATION
-
批准号:6345816
-
项目类别:
-
资助金额:$3.85万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
SUBSTANCE P-MEDIATED CARDIOVASCULAR INFLAMMATION
-
批准号:6040838
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
OXIDATIVE STRESS AND ANTIOXIDANTS IN IRON OVERLOAD
-
批准号:6537931
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Cardiomyopathy:Pro-Oxidant Role of Zidovudine (AZT)
-
批准号:7061279
-
项目类别:
-
资助金额:$33.62万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Substance P-Mediated Cardiovascular Inflammation
-
批准号:6680138
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Substance P-Mediated Cardiovascular Inflammation
-
批准号:6844695
-
项目类别:
-
资助金额:$30.4万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Cardiomyopathy: Pro-Oxidant Role of Zidovudine (AZT)
-
批准号:7229466
-
项目类别:
-
资助金额:$32.64万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
Cardiomyopathy:Pro-Oxidant Role of Zidovudine (AZT)
-
批准号:6937241
-
项目类别:
-
资助金额:$34.43万
-
财政年份:2000
-
负责人:William Bernard Weglicki
-
依托单位:
海外基金